Suppression of ovarian follicle development by nano TiO2 is associated with TGF‐β‐mediated signaling pathways
article
OA: closed
CC0
AI-generated summary
Nano TiO2 exposure suppressed ovarian follicle development in mice by disrupting TGF-β, PI3K/AKT/mTOR, and AKT/p70S6K-rpS6/TSC/mTOR signaling pathways.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Abstract Nanoparticulate titanium dioxide (nano TiO 2 ) is extensively applied in biological tissue engineering materials, food additives, cosmetics, and sunscreens. Numerous studies to date have demonstrated that nano TiO 2 penetrates through the digestive system and possibly the blood circulation, leading to accumulation in the ovary and consequent reproductive toxicity. However, the mechanisms underlying the toxic effects of nano TiO 2 on the female reproductive system remain to be established. In this study, female mice were exposed to different doses of nano TiO 2 (1.25, 2.5, or 5 mg/kg body weight) via intragastric administration for 60 consecutive days, followed by investigation of follicular development, regulation of TGF‐β‐mediated signaling pathways, and expression of the pathway components. Subchronic exposure to nano TiO 2 induced a decrease in the number of primordial, secondary, and antral follicles and corpus luteum and concomitant increase in atretic follicles. Furthermore, follicular development disorder induced by nano TiO 2 was associated with upregulation of TGF‐β1, TGF‐βR1, PTEN, and Foxo3a involved in cell growth and apoptosis and downregulation of several growth factors (PI3K, AKT, p‐mTOR, p70S6K, p‐p70S6K1, rpS6, p‐rpS6, TSC1, and TSC2) in mouse ovaries. Our data collectively implied that suppression of ovarian follicle development by nano TiO 2 was triggered by dysfunction of the TGF‐β, PI3K/AKT/mTOR, and AKT/p70S6K‐rpS6/TSC/mTOR pathways. The adverse effects of nano TiO 2 on follicular development highlights the necessity for caution in the use of nanomaterials in the food industry. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 414–422, 2019.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (56)
- W173536926 via openalex
- W323950995 via openalex
- W943095070 via openalex
- W1701092691 via openalex
- W1846142415 via openalex
- W1966318343 via openalex
- W1971991362 via openalex
- W1977669141 via openalex
- W1980019078 via openalex
- W1984736455 via openalex
- W1986262600 via openalex
- W1992004872 via openalex
- W1998925060 via openalex
- W2002003950 via openalex
- W2005303138 via openalex
- W2022786065 via openalex
- W2031052102 via openalex
- W2034623756 via openalex
- W2040558826 via openalex
- W2045282097 via openalex
- W2049759529 via openalex
- W2050554989 via openalex
- W2063684370 via openalex
- W2065678329 via openalex
- W2082849114 via openalex
- W2092278162 via openalex
- W2094622646 via openalex
- W2100168611 via openalex
- W2101218401 via openalex
- W2115742485 via openalex
- W2121410057 via openalex
- W2129072528 via openalex
- W2129585918 via openalex
- W2132563186 via openalex
- W2136656707 via openalex
- W2137108265 via openalex
- W2139001496 via openalex
- W2144258881 via openalex
- W2147114673 via openalex
- W2147800157 via openalex
- W2152512428 via openalex
- W2152638739 via openalex
- W2157415584 via openalex
- W2157485244 via openalex
- W2159868799 via openalex
- W2161437953 via openalex
- W2195687926 via openalex
- W2407076912 via openalex
- W2468363339 via openalex
- W2570459373 via openalex
- W2617019395 via openalex
- W2619713782 via openalex
- W2747858758 via openalex
- W2749260832 via openalex
- W2799450501 via openalex
- W4229704949 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK